Bacil Pharma Ltd. | Small-cap | Healthcare
₹37.68
-4.56%
| Bacil Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 0
Operating Income -2.5M
Net Income 4.0M

Balance Sheet Metrics

Total Assets 256.0M
Total Liabilities 1.7M
Shareholders Equity 254.3M
Debt to Equity 0.01

Cash Flow Metrics

Operating Cash Flow 4.0M
Free Cash Flow 4.0M

Revenue & Profitability Trend

Bacil Pharma Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 0 0 0 0 0
Cost of Goods Sold - 0 0 0 0
Gross Profit - 0 0 0 0
Operating Expenses 1.1M 878.5K 880.6K 949.2K 882.5K
Operating Income -2.5M -1.9M -1.8M -1.6M -1.4M
Pre-tax Income 4.1M -589.8K -1.0M -38.6M -2.4M
Income Tax 34.0K -720 -180 -2.2K -4.3K
Net Income 4.0M -590.5K -1.0M -38.6M -2.4M
EPS (Diluted) - -₹0.10 -₹0.17 -₹6.55 -₹0.41

Income Statement Trend

Bacil Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 29.1M 521.0K 2.3M 3.2M 3.0M
Non-Current Assets 226.9M 12.7M 9.0M 9.6M 37.9M
Total Assets 256.0M 13.3M 11.3M 12.7M 40.9M
Liabilities
Current Liabilities 1.7M 1.1M 279.2K 471.8K 27.0M
Non-Current Liabilities 0 0 0 0 0
Total Liabilities 1.7M 1.1M 279.2K 471.8K 27.0M
Equity
Total Shareholders Equity 254.3M 12.1M 11.0M 12.2M 13.9M

Balance Sheet Composition

Bacil Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 4.1M -590.0K -1.0M -38.6M -2.4M
Operating Cash Flow 4.0M -107.0K -1.4M -40.0M -3.8M
Investing Activities
Capital Expenditures - 0 0 0 0
Investing Cash Flow - 1.0K 0 0 0
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 20.8M -628.0K 628.0K 3.3M -
Free Cash Flow 4.0M -29.0K -1.5M -40.1M -4.0M

Cash Flow Trend

Bacil Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 54.61
Price to Book 1.16

Profitability Ratios

Profit Margin 0.00%
Operating Margin 0.00%
Return on Equity 3.03%
Return on Assets -1.18%

Financial Health

Current Ratio 17.21
Debt to Equity 0.64
Beta 0.33

Per Share Data

EPS (TTM) ₹0.69
Book Value per Share ₹32.60

Financial data is updated regularly. All figures are in the company's reporting currency.